Your browser doesn't support javascript.
loading
COVID-19: Significance of antibodies.
Assadiasl, Sara; Fatahi, Yousef; Zavvar, Mahdi; Nicknam, Mohammad Hossein.
Afiliación
  • Assadiasl S; Molecular Immunology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Fatahi Y; Department of Pharmaceutical Nanotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
  • Zavvar M; Nanotechnology Research Centre, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
  • Nicknam MH; Department of Medical Laboratory Sciences, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran.
Hum Antibodies ; 28(4): 287-297, 2020.
Article en En | MEDLINE | ID: mdl-32986664
The newly emerged severe acute respiratory syndrome-related coronavirus-2 (SARS-CoV-2) has recently caused pandemic Coronavirus Disease-2019 (COVID-19). Considering the serious medical, economic and social consequences of this pandemic and the lack of definite medication and vaccine it is necessary to describe natural immune responses to the SARS-CoV-2 in order to exploit them for treating the patients and monitoring the general population. Moreover, detecting the most immunogenic antigens of the virus is fundamental for designing effective vaccines. Antibodies being valuable for diagnostic therapeutic and protective purposes are suitable to be addressed in this context. Herein, we have summarized the findings of serological investigations and the outcomes of neutralizing antibodies administration in COVID-19 patients.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pandemias / SARS-CoV-2 / COVID-19 / Anticuerpos Antivirales Límite: Animals / Humans Idioma: En Revista: Hum Antibodies Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pandemias / SARS-CoV-2 / COVID-19 / Anticuerpos Antivirales Límite: Animals / Humans Idioma: En Revista: Hum Antibodies Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Países Bajos